Research shows anthocyanins slow tumor growth and reduce metastasis in mice — Evidence Review
Published in International journal of molecular sciences, by researchers from Texas A&M University College of Agriculture and Life Sciences, Texas A&M AgriLife Research, College of Veterinary Medicine and Biomedical Sciences
Researched by
— the AI search engine for science
Table of Contents
Researchers at Texas A&M University found that anthocyanins from dark sweet cherries slowed tumor growth and reduced metastasis in a mouse model of triple-negative breast cancer. These findings align with a broad body of existing research supporting the anticancer potential of anthocyanins.
- Multiple in vitro studies have shown that anthocyanins and their aglycones inhibit cancer cell proliferation and metastasis across several cancer types, including colon, breast, lung, and melanoma, supporting the new study’s results 1 2 3 6 7 10.
- Mechanistic research and comprehensive reviews consistently highlight antioxidant, anti-inflammatory, anti-metastatic, and anti-resistance effects of anthocyanins, mirroring the gene expression and metastasis-related findings of the Texas A&M study 8 9 11.
- While most prior research has been conducted in cell cultures, the new animal study strengthens evidence for in vivo effects and suggests anthocyanins may enhance existing therapies or prevent treatment resistance 8 9.
Study Overview and Key Findings
Triple-negative breast cancer is an aggressive subtype lacking targeted treatment options, with a high risk of metastasis and recurrence. The new study aimed to address this challenge by exploring whether anthocyanins—the pigments giving dark sweet cherries their color—could help suppress tumor growth, reduce spread, and influence gene activity associated with therapy resistance. Notably, the researchers assessed both tumor progression and metastatic burden, as metastasis is the major cause of mortality in breast cancer, and evaluated anthocyanin effects both alone and in combination with chemotherapy.
| Property | Value |
|---|---|
| Study Year | 2025 |
| Organization | Texas A&M University College of Agriculture and Life Sciences, Texas A&M AgriLife Research, College of Veterinary Medicine and Biomedical Sciences |
| Journal Name | International journal of molecular sciences |
| Authors | Ana Nava-Ochoa, Lauren W Stranahan, Rodrigo San-Cristobal, Susanne U Mertens-Talcott, Giuliana D Noratto |
| Population | Mice with implanted tumors |
| Methods | Animal Study |
| Outcome | Tumor growth, metastasis, gene activity related to treatment resistance |
| Results | Anthocyanins slowed tumor growth and reduced metastasis. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus paper database, which contains over 200 million research papers. The following search queries were used:
- anthocyanins tumor growth inhibition
- metastasis reduction anthocyanins effects
- cancer treatment anthocyanins mechanisms
Summary Table: Related Study Topics and Findings
| Topic | Key Findings |
|---|---|
| Do anthocyanins inhibit tumor growth and cancer cell proliferation? | - Anthocyanins and anthocyanidins inhibit proliferation of various human cancer cell lines, including breast, colon, and melanoma, in vitro 1 2 3 4 10. - The chemical structure of anthocyanins influences their growth-inhibitory potency 1 4 12. |
| Can anthocyanins reduce cancer metastasis and invasion? | - Anthocyanins inhibit migration, invasion, and metastasis of cancer cells by downregulating MMPs and u-PA expression in vitro and in animal models 6 7. - Anthocyanins reduce metastatic spread in both cell-based and animal studies 7 8. |
| What are the mechanisms by which anthocyanins exert anticancer effects? | - Anthocyanins show antioxidant, anti-inflammatory, anti-mutagenic, and apoptosis-inducing activities in cancer models 8 9 11. - They can modulate gene expression related to metastasis, proliferation, and drug resistance 8 9 12 13. |
| Do anthocyanins have potential as adjuncts to standard cancer therapies? | - Anthocyanins may enhance sensitivity to chemotherapy and reverse drug resistance in cancer cells, suggesting possible roles as adjuvants 8 9. - Animal and in vitro studies report low toxicity and minimal side effects at effective concentrations 9. |
Do anthocyanins inhibit tumor growth and cancer cell proliferation?
A large body of in vitro research has shown that anthocyanins and their aglycones (anthocyanidins) inhibit proliferation of various cancer cell lines, including breast, colon, lung, and melanoma cells 1 2 3 4 10. The potency of these effects varies with the anthocyanin's chemical structure, with certain forms exhibiting stronger inhibition. The Texas A&M mouse study extends these findings to an in vivo model, providing additional evidence that anthocyanins can suppress tumor growth beyond cell cultures.
- Multiple studies demonstrate significant growth inhibition of cancer cells by anthocyanin-rich extracts and aglycones 1 2 3 4.
- Chemical structure, such as glycosylation and acylation, impacts inhibitory potency; nonacylated, monoglycosylated anthocyanins are often most effective 1 4 12.
- Blueberry anthocyanin and anthocyanidin extracts reduce melanoma cell viability and proliferation and induce apoptosis 10.
- The new animal study supports and builds upon these in vitro results by showing in vivo tumor growth inhibition.
Can anthocyanins reduce cancer metastasis and invasion?
Evidence from both cell-based and animal studies suggests anthocyanins can suppress metastasis, the primary cause of cancer mortality 6 7 8. Mechanisms include downregulation of MMPs and u-PA, reduction of gene expression related to invasion, and inhibition of cell motility. The Texas A&M study’s finding of reduced metastatic spread in mice is consistent with these earlier reports.
- Anthocyanins from mulberries and black rice inhibit migration and invasion in lung and other cancer cell lines, linked to lower MMP and u-PA expression 6 7.
- Black rice anthocyanins suppress metastatic behavior in both cell cultures and animal models 7.
- Reviews and mechanistic studies confirm anthocyanins’ anti-metastatic properties, with potential clinical relevance 8.
- The new study’s demonstration of reduced lung and organ metastasis in mice aligns with these findings.
What are the mechanisms by which anthocyanins exert anticancer effects?
Anthocyanins act through multiple biological pathways, including antioxidant, anti-inflammatory, pro-apoptotic, and anti-mutagenic effects 8 9 11. They influence gene expression associated with cell proliferation, metastasis, and drug resistance, and may inhibit signaling pathways such as EGFR and kinases. The Texas A&M study identifies downregulation of metastasis- and resistance-associated genes in tumor tissue, matching mechanisms reported in the literature.
- Anthocyanins can induce apoptosis, cell cycle arrest, and pyroptosis in cancer cells 8 11 13.
- They modulate gene expression relevant to metastasis, resistance, and cell survival 8 9 12 13.
- Specific anthocyanins inhibit kinase and EGFR activity, interfering with cancer growth signals 5 12.
- The new study’s gene expression findings support these mechanistic insights.
Do anthocyanins have potential as adjuncts to standard cancer therapies?
There is growing interest in anthocyanins as dietary adjuvants to enhance standard cancer therapies. Studies suggest they may increase sensitivity to chemotherapy agents and help overcome drug resistance 8 9. The Texas A&M study’s combination of anthocyanins with doxorubicin, which improved tumor suppression without added toxicity, provides initial in vivo support for this strategy.
- Reviews note that anthocyanins may reverse drug resistance and increase the effectiveness of conventional treatments 8 9.
- Animal and in vitro studies generally report low toxicity and good tolerability for anthocyanin supplementation 9.
- The new study’s results suggest that anthocyanins could be integrated safely with chemotherapy, but human trials are needed.
Future Research Questions
Although preclinical evidence for anthocyanins’ anticancer effects is substantial, important questions remain regarding their practical application, safety, and mechanisms in humans. Future research should focus on clarifying these areas and translating findings from animal and cell studies into clinical relevance.
| Research Question | Relevance |
|---|---|
| How do anthocyanins affect tumor growth and metastasis in human clinical trials? | Most evidence to date comes from in vitro or animal studies; rigorous human clinical trials are needed to establish efficacy and safety in cancer patients 8 9. |
| What are the optimal doses and forms of anthocyanins for anticancer effects in humans? | Determining effective and safe dosing, as well as which anthocyanin sources or structures are most beneficial, is crucial for potential therapeutic use 4 9 12. |
| Can anthocyanins improve the efficacy or reduce side effects of standard chemotherapy in cancer patients? | Early evidence suggests possible synergy with chemotherapy and potential to reduce toxicity, but this needs validation in clinical settings 8 9. |
| What are the molecular mechanisms by which anthocyanins influence treatment resistance in cancer? | Understanding how anthocyanins modulate resistance pathways may help integrate them into personalized or combination therapies 8 12. |
| Are there any long-term safety concerns with high dose anthocyanin supplementation in cancer patients? | While animal and cell studies report low toxicity, systematic evaluation of safety and potential interactions is needed for long-term or high-dose use in humans 9. |